{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:07:40Z","timestamp":1792559260464,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL060906"],"award-info":[{"award-number":["HL060906"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK038226"],"award-info":[{"award-number":["DK038226"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK59637"],"award-info":[{"award-number":["DK59637"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK20593"],"award-info":[{"award-number":["DK20593"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK095761"],"award-info":[{"award-number":["DK095761"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK081662"],"award-info":[{"award-number":["DK081662"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX002025-01"],"award-info":[{"award-number":["I01 BX002025-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 RR024975"],"award-info":[{"award-number":["UL1 RR024975"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000445"],"award-info":[{"award-number":["UL1 TR000445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00125-017-4260-0","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T15:44:38Z","timestamp":1490715878000},"page":"1066-1075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids contribute to insulin sensitivity in mice and in humans"],"prefix":"10.1007","volume":"60","author":[{"given":"Mahesha H.","family":"Gangadhariah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake W.","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Lantier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Chiusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge H.","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Imig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Luther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"4260_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840\u2013846","journal-title":"Nature"},{"key":"4260_CR2","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/ATVBAHA.111.241885","volume":"32","author":"G Reaven","year":"2012","unstructured":"Reaven G (2012) Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol 32:1754\u20131759","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4260_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.00021.2011","volume":"92","author":"JD Imig","year":"2012","unstructured":"Imig JD (2012) Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev 92:101\u2013130","journal-title":"Physiol Rev"},{"key":"4260_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1440-1681.2000.03349.x","volume":"27","author":"RJ Roman","year":"2000","unstructured":"Roman RJ, Maier KG, Sun CW, Harder DR, Alonso-Galicia M (2000) Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol 27:855\u2013865","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4260_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","volume":"43","author":"AA Spector","year":"2004","unstructured":"Spector AA, Fang X, Snyder GD, Weintraub NL (2004) Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43:55\u201390","journal-title":"Prog Lipid Res"},{"key":"4260_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00424-010-0804-6","volume":"459","author":"WB Campbell","year":"2010","unstructured":"Campbell WB, Fleming I (2010) Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Arch 459:881\u2013895","journal-title":"Pflugers Arch"},{"key":"4260_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MNH.0b013e32835d911e","volume":"22","author":"J Capdevila","year":"2013","unstructured":"Capdevila J, Wang W (2013) Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension. Curr Opin Nephrol Hypertens 22:163\u2013169","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4260_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/HYPERTENSIONAHA.111.178475","volume":"59","author":"P Sun","year":"2012","unstructured":"Sun P, Antoun J, Lin DH et al (2012) Cyp2c44 epoxygenase is essential for preventing the renal sodium absorption during increasing dietary potassium intake. Hypertension 59:339\u2013347","journal-title":"Hypertension"},{"key":"4260_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1124\/jpet.104.067819","volume":"310","author":"TC DeLozier","year":"2004","unstructured":"DeLozier TC, Tsao CC, Coulter SJ et al (2004) CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products. J Pharmacol Exp Ther 310:845\u2013854","journal-title":"J Pharmacol Exp Ther"},{"key":"4260_CR10","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1074\/jbc.M113.508416","volume":"289","author":"JH Capdevila","year":"2014","unstructured":"Capdevila JH, Pidkovka N, Mei S et al (2014) The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt. J Biol Chem 289:4377\u20134386","journal-title":"J Biol Chem"},{"key":"4260_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1124\/jpet.109.157545","volume":"331","author":"K Sodhi","year":"2009","unstructured":"Sodhi K, Inoue K, Gotlinger KH et al (2009) Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Ther 331:906\u2013916","journal-title":"J Pharmacol Exp Ther"},{"key":"4260_CR12","doi-asserted-by":"publisher","first-page":"E500","DOI":"10.1152\/ajpendo.00370.2011","volume":"302","author":"KN Theken","year":"2012","unstructured":"Theken KN, Deng Y, Schuck RN et al (2012) Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism. Am J Physiol Endocrinol Metab 302:E500\u2013E509","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4260_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1124\/jpet.110.167544","volume":"334","author":"P Luo","year":"2010","unstructured":"Luo P, Chang HH, Zhou Y et al (2010) Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis. J Pharmacol Exp Ther 334:430\u2013438","journal-title":"J Pharmacol Exp Ther"},{"key":"4260_CR14","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1073\/pnas.1103482108","volume":"108","author":"A Luria","year":"2011","unstructured":"Luria A, Bettaieb A, Xi Y et al (2011) Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci U S A 108:9038\u20139043","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4260_CR15","doi-asserted-by":"publisher","first-page":"758614","DOI":"10.1155\/2012\/758614","volume":"2012","author":"A Iyer","year":"2012","unstructured":"Iyer A, Kauter K, Alam MA et al (2012) Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp Diabetes Res 2012:758614","journal-title":"Exp Diabetes Res"},{"key":"4260_CR16","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1172\/JCI67166","volume":"123","author":"KJ Mather","year":"2013","unstructured":"Mather KJ, Steinberg HO, Baron AD (2013) Insulin resistance in the vasculature. J Clin Invest 123:1003\u20131004","journal-title":"J Clin Invest"},{"key":"4260_CR17","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1007\/s00125-010-1756-2","volume":"53","author":"A Zanchi","year":"2010","unstructured":"Zanchi A, Maillard M, Jornayvaz FR et al (2010) Effects of the peroxisome proliferator-activated receptor (PPAR)-\u03b3 agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals. Diabetologia 53:1568\u20131575","journal-title":"Diabetologia"},{"key":"4260_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/01.HYP.0000176237.74820.75","volume":"46","author":"JD Imig","year":"2005","unstructured":"Imig JD, Zhao X, Zaharis CZ et al (2005) An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 46:975\u2013981","journal-title":"Hypertension"},{"key":"4260_CR19","doi-asserted-by":"publisher","first-page":"12840","DOI":"10.1074\/jbc.M109.081554","volume":"285","author":"A Pozzi","year":"2010","unstructured":"Pozzi A, Popescu V, Yang S et al (2010) The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated. J Biol Chem 285:12840\u201312850","journal-title":"J Biol Chem"},{"key":"4260_CR20","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1007\/s00125-011-2158-9","volume":"54","author":"JM Luther","year":"2011","unstructured":"Luther JM, Luo P, Kreger MT et al (2011) Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. Diabetologia 54:2152\u20132163","journal-title":"Diabetologia"},{"key":"4260_CR21","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.2337\/db11-0538","volume":"60","author":"MS Remedi","year":"2011","unstructured":"Remedi MS, Agapova SE, Vyas AK, Hruz PW, Nichols CG (2011) Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes. Diabetes 60:2515\u20132522","journal-title":"Diabetes"},{"key":"4260_CR22","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/sj.bjp.0702946","volume":"128","author":"CA Williams","year":"1999","unstructured":"Williams CA, Shih MF, Taberner PV (1999) Sustained improvement in glucose homeostasis in lean and obese mice following chronic administration of the \u03b23 agonist SR 58611A. Br J Pharmacol 128:1586\u20131592","journal-title":"Br J Pharmacol"},{"key":"4260_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ab.2008.02.021","volume":"377","author":"W Mizunoya","year":"2008","unstructured":"Mizunoya W, Wakamatsu J, Tatsumi R, Ikeuchi Y (2008) Protocol for high-resolution separation of rodent myosin heavy chain isoforms in a mini-gel electrophoresis system. Anal Biochem 377:111\u2013113","journal-title":"Anal Biochem"},{"key":"4260_CR24","doi-asserted-by":"crossref","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394C\n                           t Method. Methods 25:402\u2013408","DOI":"10.1006\/meth.2001.1262"},{"key":"4260_CR25","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/HJH.0b013e32835e8227","volume":"31","author":"K Gilbert","year":"2013","unstructured":"Gilbert K, Nian H, Yu C, Luther JM, Brown NJ (2013) Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension. J Hypertens 31:820\u2013829","journal-title":"J Hypertens"},{"key":"4260_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2337\/dc08-1862","volume":"32","author":"KD Hill","year":"2009","unstructured":"Hill KD, Eckhauser AW, Marney A, Brown NJ (2009) Phosphodiesterase 5 inhibition improves \u03b2-cell function in metabolic syndrome. Diabetes Care 32:857\u2013859","journal-title":"Diabetes Care"},{"key":"4260_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/HYPERTENSIONAHA.111.189589","volume":"59","author":"K Ayers","year":"2012","unstructured":"Ayers K, Byrne LM, DeMatteo A, Brown NJ (2012) Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome. Hypertension 59:893\u2013898","journal-title":"Hypertension"},{"key":"4260_CR28","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/0006-291X(92)91877-S","volume":"182","author":"A Karara","year":"1992","unstructured":"Karara A, Wei S, Spady D, Swift L, Capdevila JH, Falck JR (1992) Arachidonic acid epoxygenase: structural characterization and quantification of epoxyeicosatrienoates in plasma. Biochem Biophys Res Commun 182:1320\u20131325","journal-title":"Biochem Biophys Res Commun"},{"key":"4260_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/edrv-6-1-45","volume":"6","author":"RN Bergman","year":"1985","unstructured":"Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45\u201386","journal-title":"Endocr Rev"},{"key":"4260_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1089\/152091503322641060","volume":"5","author":"RC Boston","year":"2003","unstructured":"Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN (2003) MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 5:1003\u20131015","journal-title":"Diabetes Technol Ther"},{"key":"4260_CR31","unstructured":"R Core Team (2014) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available from \n                    www.R-project.org\n                    \n                  \/. Accessed 8 Mar 2017."},{"key":"4260_CR32","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1152\/ajpendo.90563.2008","volume":"296","author":"DH Wasserman","year":"2009","unstructured":"Wasserman DH (2009) Four grams of glucose. Am J Physiol Endocrinol Metab 296:E11\u2013E21","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4260_CR33","doi-asserted-by":"publisher","first-page":"21618","DOI":"10.1074\/jbc.M113.481077","volume":"288","author":"EL Klett","year":"2013","unstructured":"Klett EL, Chen S, Edin ML et al (2013) Diminished acyl-CoA synthetase isoform 4 activity in INS 832\/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion. J Biol Chem 288:21618\u201321629","journal-title":"J Biol Chem"},{"key":"4260_CR34","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2337\/db12-1502","volume":"62","author":"L Kang","year":"2013","unstructured":"Kang L, Lantier L, Kennedy A et al (2013) Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance. Diabetes 62:1888\u20131896","journal-title":"Diabetes"},{"key":"4260_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2337\/db10-1116","volume":"60","author":"L Kang","year":"2011","unstructured":"Kang L, Ayala JE, Lee-Young RS et al (2011) Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin \u03b12\u03b21 in mice. Diabetes 60:416\u2013426","journal-title":"Diabetes"},{"key":"4260_CR36","doi-asserted-by":"publisher","first-page":"E1097","DOI":"10.1152\/ajpendo.00216.2014","volume":"307","author":"CY Shim","year":"2014","unstructured":"Shim CY, Kim S, Chadderdon S et al (2014) Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume. Am J Physiol Endocrinol Metab 307:E1097\u2013E1104","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4260_CR37","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1159\/000374011","volume":"35","author":"W Chen","year":"2015","unstructured":"Chen W, Yang S, Ping W, Fu X, Xu Q, Wang J (2015) CYP2J2 and EETs protect against lung ischemia\/reperfusion injury via anti-inflammatory effects in vivo and in vitro. Cell Physiol Biochem 35:2043\u20132054","journal-title":"Cell Physiol Biochem"},{"key":"4260_CR38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/ijmm.2014.1844","volume":"34","author":"W Liu","year":"2014","unstructured":"Liu W, Wang B, Ding H, Wang DW, Zeng H (2014) A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-\u03b1 activity. Int J Mol Med 34:725\u2013732","journal-title":"Int J Mol Med"},{"key":"4260_CR39","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1172\/JCI114644","volume":"85","author":"M Laakso","year":"1990","unstructured":"Laakso M, Edelman SV, Brechtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85:1844\u20131852","journal-title":"J Clin Invest"},{"key":"4260_CR40","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.2337\/db12-0271","volume":"61","author":"EJ Barrett","year":"2012","unstructured":"Barrett EJ, Rattigan S (2012) Muscle perfusion: its measurement and role in metabolic regulation. Diabetes 61:2661\u20132668","journal-title":"Diabetes"},{"key":"4260_CR41","doi-asserted-by":"publisher","first-page":"35105","DOI":"10.1074\/jbc.M201575200","volume":"277","author":"LA Cowart","year":"2002","unstructured":"Cowart LA, Wei S, Hsu MH et al (2002) The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J Biol Chem 277:35105\u201335112","journal-title":"J Biol Chem"},{"key":"4260_CR42","first-page":"44","volume":"13","author":"CC White","year":"2013","unstructured":"White CC, Feng Q, Cupples LA et al (2013) CYP4A11 variant is associated with high-density lipoprotein cholesterol in women. Pharm J 13:44\u201351","journal-title":"Pharm J"},{"key":"4260_CR43","doi-asserted-by":"crossref","unstructured":"Ramirez CE, Shuey MM, Milne GL, et al. (2014) Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans. Prostaglandins Other Lipid Mediat 113\u2013115: 38\u201344","DOI":"10.1016\/j.prostaglandins.2014.08.001"},{"key":"4260_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1055\/s-0029-1243604","volume":"118","author":"CP Wang","year":"2010","unstructured":"Wang CP, Hung WC, Yu TH et al (2010) Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history. Exp Clin Endocrinol Diabetes 118:346\u2013352","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"4260_CR45","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1210\/endo.138.3.4970","volume":"138","author":"DC Zeldin","year":"1997","unstructured":"Zeldin DC, Foley J, Boyle JE et al (1997) Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology 138:1338\u20131346","journal-title":"Endocrinology"},{"key":"4260_CR46","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/0006-291X(83)90843-4","volume":"114","author":"JR Falck","year":"1983","unstructured":"Falck JR, Manna S, Moltz J, Chacos N, Capdevila J (1983) Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets. Biochem Biophys Res Commun 114:743\u2013749","journal-title":"Biochem Biophys Res Commun"},{"key":"4260_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0005-2760(85)90023-2","volume":"835","author":"J Turk","year":"1985","unstructured":"Turk J, Wolf BA, Comens PG, Colca J, Jakschik B, McDaniel ML (1985) Arachidonic acid metabolism in isolated pancreatic islets. IV. Negative ion-mass spectrometric quantitation of monooxygenase product synthesis by liver and islets. Biochim Biophys Acta 835:1\u201317","journal-title":"Biochim Biophys Acta"},{"key":"4260_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1152\/physrev.00027.2009","volume":"90","author":"TP Flagg","year":"2010","unstructured":"Flagg TP, Enkvetchakul D, Koster JC, Nichols CG (2010) Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev 90:799\u2013829","journal-title":"Physiol Rev"},{"key":"4260_CR49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1113\/jphysiol.2006.113985","volume":"575","author":"T Lu","year":"2006","unstructured":"Lu T, Ye D, Wang X et al (2006) Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J Physiol 575:627\u2013644","journal-title":"J Physiol"},{"key":"4260_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-016-2821-z","volume":"422","author":"VR Yadav","year":"2016","unstructured":"Yadav VR, Hong KL, Zeldin DC, Nayeem MA (2016) Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels. Mol Cell Biochem 422:197\u2013206","journal-title":"Mol Cell Biochem"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4260-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4260-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4260-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T17:31:12Z","timestamp":1589563872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4260-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["4260"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4260-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]},"assertion":[{"value":"26 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data will be made available upon request.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This work was supported by grants from the NIH (DK095761, DK081662, DK038226, HL060906), the Veteran Affairs (I01 BX002025-01) and the Vanderbilt Mouse Metabolic Phenotyping Center (DK59637). Clinical studies were supported by UL1 RR024975 and UL1 TR000445 from NCATS\/NIH (Vanderbilt Institute for Clinical and Translational Research). Hormone assays and islet stimulation studies were performed by the Vanderbilt Diabetes Research and Training Center Hormone Assay Core Lab and Islet Procurement and Analysis Core Lab (DK20593). AP is the recipient of a VA Senior Research Career Scientist award.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"MHG, BWD, LL, JLG, LK, DHW, MC, CFC, AP, and JML designed the experiments. MHG, BWD, LL, LK, JLG, MC, JD, PL, JDI, AP and JML collected data. MHG, DHW, JHC, JDI, CY, JLG, AP and JML analysed and interpreted data. All authors critically reviewed the manuscript and approved the final version. JML and AP drafted the manuscript and are the guarantors of this work as a whole.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}